Drug Profile
SK 306
Latest Information Update: 27 Oct 1999
Price :
$50
*
At a glance
- Originator Sato
- Developer Nonindustrial source; Sato
- Class Antibacterials
- Mechanism of Action Dihydropteroate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 27 Oct 1999 No-Development-Reported for Bacterial infections in Japan (PO)
- 20 Feb 1997 New profile
- 20 Feb 1997 Investigation in Bacterial infections in Japan (PO)